Influenza B Virus Antikörper
-
- Target
- Influenza B Virus
- Reaktivität
- Influenza B Virus
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Fluorescence Microscopy (FM)
- Spezifität
- Purified virions
- Kreuzreaktivität (Details)
- Does not cross-react with Influenza A, Para 1-3, RSV or Adenovirus, Negative vs. monkey kidney cells by indirect immunofluorescence
- Aufreinigung
- This product consists of the purified IgG fraction of the above antiserum.
- Reinheit
- > 95 %
- Immunogen
- Yamagata strain of Influenza B
- Isotyp
- IgG
-
-
- Applikationshinweise
- TITER : >1:1,000 by indirect immunofluorescence, Potential applications for this product are numerous including ELISA, fluorescence microscopy, immunoblotting and immunohistochemistry. In addition, this product may be used in place of neat antiserum in almost any appropriate antibody-based technique. It is also suitable for conjugation purposes.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- The product is formulated in a phosphate saline buffer (0.01M, pH 7.2) containing 0.1 % sodium azide preservative. No stabilizing proteins have been added.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Recommended short term (<6 months) storage is liquid at 2-8°C. For longer term storage, aliquot and freeze.
-
- Target
- Influenza B Virus
- Substanzklasse
- Virus
-